Biofarmacija, UAB - financials and debts

Company age: 14 y. 9 mo.

Update

Biofarmacija - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 2,545,618 3,762,649 4,320,067 5,493,211 5,395,967 6,430,016 7,653,714 9,009,626
Profit before tax 394,801 514,981 1,261,497 896,681 342,089 895,932 950,188 1,042,306
Net profit 333,183 433,792 1,070,885 763,128 320,600 684,842 813,492 862,314
Equity 1,397,002 1,830,794 2,901,679 3,664,808 3,792,048 4,476,890 5,290,382 4,152,696
Liabilities 915,977 776,222 1,277,515 1,155,992 2,122,570 2,011,953 1,229,158 2,553,567
Non-current assets 909,141 546,073 1,181,792 1,731,682 2,276,741 2,498,821 1,216,169 1,549,024
Current assets 1,398,517 2,058,607 2,951,182 3,089,118 3,637,877 3,988,391 5,302,048 5,155,248
Total assets 2,307,658 2,604,680 4,132,974 4,820,800 5,914,618 6,487,212 6,518,217 6,704,272
Taxes paid
STI taxes - - - - - 756,011 695,392 910,701
Social insurance contributions - - - - - 95,436 95,615 128,843
Financial indicators
Revenue change y/y +28.7% +47.8% +14.8% +27.2% -1.8% +19.2% +19.0% +17.7%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 14.4% 16.7% 25.9% 15.8% 5.4% 10.6% 12.5% 12.9%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 23.8% 23.7% 36.9% 20.8% 8.5% 15.3% 15.4% 20.8%
Profit margin Net profit margin. Shows the overall profitability of the company. 13.1% 11.5% 24.8% 13.9% 5.9% 10.7% 10.6% 9.6%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 15.5% 13.7% 29.2% 16.3% 6.3% 13.9% 12.4% 11.6%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.7 0.4 0.4 0.3 0.6 0.4 0.2 0.6
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 314,923 249,458 229,384 244,143 233,761 292,273 425,206 489,210

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Sales revenue

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Biofarmacija - Social security debts

From To Debt, €
2025-10-16 2025-10-19 318.54
2025-02-10 2025-02-10 0.05
2025-01-22 2025-01-29 0.05
2024-12-17 2024-12-20 49.56
2024-04-23 2024-05-14 6.51
2024-01-23 2024-02-13 12.65
2023-11-16 2023-11-20 7025.37
2023-02-10 2023-02-12 0.01

Biofarmacija - VMI tax arrears

From To Overdue, €
2026-05-03 2026-05-03 18599.22
2026-05-01 2026-05-02 18594.2
2026-04-30 2026-04-30 18579.71

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Biofarmacija, UAB (code 302701106) is a Private Limited Liability Company engaged in the wholesale of other food. In 2025, the company generated revenue of €9.01M, up 17.7% year on year and 40.1% over two years. Net profit reached €862.3K, with a profit margin of 9.6%, slightly below the 10.6% reported in 2024 and 10.7% in 2023. The three-year trajectory shows steady top-line growth from €6.43M in 2023 to €7.65M in 2024 and €9.01M in 2025, while net profit increased from €684.8K to €813.5K and then to €862.3K. Total assets were €6.70M in 2025, compared with €6.49M in 2023 and €6.52M in 2024. Equity stood at €4.15M and liabilities at €2.55M, indicating a moderate leverage position with a debt-to-equity ratio of 0.61. Return on equity was 20.8% and return on assets 12.9%. Asset turnover was 1.34x. Revenue per employee was €500.5K and profit per employee €47.9K.